Global Patent Index - EP 1268543 A2

EP 1268543 A2 20030102 - METHODS AND MATERIALS RELATING TO STEM CELL GROWTH FACTOR-LIKE POLYPEPTIDES AND POLYNUCLEOTIDES

Title (en)

METHODS AND MATERIALS RELATING TO STEM CELL GROWTH FACTOR-LIKE POLYPEPTIDES AND POLYNUCLEOTIDES

Title (de)

VERFAHREN UND MATERIALIEN, DIE SICH AUF STAMMZELLEWACHSTUMFAKTOR-ÄHNLICHEN POLYPEPTIDE UND POLYNUKLEOTIDE BEZIEHEN

Title (fr)

METHODES ET MATERIAUX RELATIFS A DE NOUVEAUX POLYPEPTIDES ET POLYNUCLEOTIDES DU TYPE FACTEUR DE CROISSANCE DES CELLULES-SOUCHES

Publication

EP 1268543 A2 20030102 (EN)

Application

EP 01932523 A 20010405

Priority

  • US 0111208 W 20010405
  • US 54377400 A 20000405
  • US 21573300 P 20000628
  • US 75756201 A 20010109
  • US 26661401 P 20010205

Abstract (en)

[origin: WO0177169A2] The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to a novel human stem cell growth factor-like protein. These polynucleotides comprise nucleic acid sequences isolated from cDNA libraries from human testis cells (Hyseq clone identification numbers 2880984 and 2881695, from human fetal skin (Hyseq clone identification number 15375176), adult spleen (Hyseq clone identification number 14856094), and human endothelial cells (Hyseq clone identification numbers 13804756, 13687487, 13804756). Other aspects of the invention include vectors containing processes for producing novel human stem cell growth factor-like polypeptides, and antibodies specific for such polypeptides.

IPC 1-7

C07K 14/475; A61K 38/18; A61K 48/00; C07K 16/22; C12N 5/10; C12N 15/12; C12N 15/22; C12Q 1/68; G01N 33/53

IPC 8 full level

G01N 33/50 (2006.01); A61K 38/00 (2006.01); A61K 45/00 (2006.01); A61K 48/00 (2006.01); A61P 7/00 (2006.01); A61P 9/10 (2006.01); A61P 17/02 (2006.01); A61P 25/00 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 35/02 (2006.01); A61P 37/00 (2006.01); A61P 37/06 (2006.01); C07K 14/475 (2006.01); C07K 14/52 (2006.01); C07K 16/24 (2006.01); C12M 1/00 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/02 (2006.01); C12N 5/10 (2006.01); C12N 15/02 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12N 15/22 (2006.01); C12P 21/02 (2006.01); C12P 21/08 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/53 (2006.01); G01N 33/566 (2006.01)

CPC (source: EP)

A61P 7/00 (2018.01); A61P 9/10 (2018.01); A61P 17/02 (2018.01); A61P 25/00 (2018.01); A61P 29/00 (2018.01); A61P 35/00 (2018.01); A61P 35/02 (2018.01); A61P 37/00 (2018.01); A61P 37/06 (2018.01); C07K 14/475 (2013.01); A01K 2217/05 (2013.01); A61K 38/00 (2013.01); A61K 48/00 (2013.01)

Citation (search report)

See references of WO 0177169A3

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 0177169 A2 20011018; WO 0177169 A3 20020704; WO 0177169 A9 20021219; AU 5904101 A 20011023; CA 2405104 A1 20011018; EP 1268543 A2 20030102; JP 2003530124 A 20031014

DOCDB simple family (application)

US 0111208 W 20010405; AU 5904101 A 20010405; CA 2405104 A 20010405; EP 01932523 A 20010405; JP 2001575639 A 20010405